Literature DB >> 12631987

Mild to moderate influenza activity in Europe and the detection of novel A(H1N2) and B viruses during the winter of 2001-02.

W J Paget1, T J Meerhoff, N L Goddard.   

Abstract

Influenza activity in Europe during the 2001-02 influenza season was mild to moderate. Compared to historical data, the intensity was low in six countries, medium in eleven and high in one country (Spain). The dominant virus circulating in Europe was influenza A(H3N2). Two novel influenza virus strains were isolated during the 2001-02 season: influenza A(H1N2) viruses (mainly isolated in the United Kingdom and Ireland, but also in Belgium, France, Germany, the Netherlands, Portugal, Sweden, Switzerland and Romania), and influenza B viruses belonging to the B/Victoria/2/87 lineage (mainly isolated in Germany, but also sporadically in France, Italy, the Netherlands and Norway). With the exception of H1N2 virus detections in England, and Ireland and the influenza B viruses belonging to the B/Victoria/2/87 lineage in Germany, these two viruses did not circulate widely in Europe and did not play an important role in influenza activity during the 2001-02 season. An influenza B virus belonging to the B/Victoria/2/87 lineage will be included in the 2002-03 influenza vaccine. The new subtype influenza A(H1N2) is covered by the 2002-03 vaccine, as the haemagglutinin and neuraminidase components of the H1N2 viruses are antigenically similar to the vaccine components (H1N1 and H3N2).

Entities:  

Mesh:

Year:  2002        PMID: 12631987     DOI: 10.2807/esm.07.11.00373-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  8 in total

1.  Cocirculation and evolution of two lineages of influenza B viruses in europe and Israel in the 2001-2002 season.

Authors:  X Sherry Chi; Trentice V Bolar; Ping Zhao; Ruth Rappaport; Sheau-Mei Cheng
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Antibody response to influenza vaccination in splenectomized patients in Poland.

Authors:  Lidia B Brydak; Magdalena Machała; Paweł Łaguna; Roma Rokicka-Milewska
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

3.  Rapid detection and subtyping of human influenza A viruses and reassortants by pyrosequencing.

Authors:  Yi-Mo Deng; Natalie Caldwell; Ian G Barr
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

4.  The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries.

Authors:  Liana Martirosyan; W John Paget; Pernille Jorgensen; Caroline S Brown; Tamara J Meerhoff; Dmitriy Pereyaslov; Joshua A Mott
Journal:  BMC Infect Dis       Date:  2012-02-10       Impact factor: 3.090

5.  Surveillance recommendations based on an exploratory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System.

Authors:  Tamara J Meerhoff; Douglas Fleming; Ann Smith; Anne Mosnier; Arianne B van Gageldonk-Lafeber; W John Paget
Journal:  BMC Infect Dis       Date:  2006-08-09       Impact factor: 3.090

6.  A case-control study of acute respiratory tract infection in general practice patients in The Netherlands.

Authors:  Arianne B van Gageldonk-Lafeber; Marie-Louise A Heijnen; Aad I M Bartelds; Marcel F Peters; Simone M van der Plas; Berry Wilbrink
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079

7.  The evolution of human influenza A viruses from 1999 to 2006: a complete genome study.

Authors:  Karoline Bragstad; Lars P Nielsen; Anders Fomsgaard
Journal:  Virol J       Date:  2008-03-07       Impact factor: 4.099

8.  Harmonising the virological surveillance of influenza in Europe: results of an 18-country survey.

Authors:  T J Meerhoff; W J Paget; J-F Aguilera; J van der Velden
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.